NGNE
Neurogene Inc.
NASDAQ · Healthcare · Biotechnology · US
$38.60
+2.63%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-51.2%
Return on equity
-45.5%
Return on assets
-53.8%
Return on invested capital
0.00x
Asset turnover
-$86.2M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026